5-Lipoxygenase activity increases susceptibility to experimental Paracoccidioides brasiliensis infection

Infection and Immunity

Volumn 81, Issue 4, 2013, Pages 1256-1266

  Tristão, Fabrine Sales Massafera ^a   Rocha, Fernanda Agostini ^a   Moreira, Ana Paula ^a   Cunha, Fernando Queiroz ^a   Rossi, Marcos Antonio ^a   Silvaa, João Santana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; TRANSCRIPTION FACTOR T BET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME ACTIVITY; GRANULOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SOUTH AMERICAN BLASTOMYCOSIS; SURVIVAL RATE; TH1 CELL; WILD TYPE; YEAST;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GRANULOMA; INTERFERON-GAMMA; INTERLEUKIN-12; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; SURVIVAL ANALYSIS; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 84875529042     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01209-12     Document Type: Article

References (39)

1. Restrepo A, McEwen JG, Castaneda E. 2001. The habitat of Paracoccidioides brasiliensis: how far from solving the riddle?. Med. Mycol. 39:233-241.
2. Bousquet A, Dussart C, Drouillard I, Charbel EC, Boiron P. 2007. Imported mycosis: a review of paracoccidioidomycosis. Med. Mal. Infect. 37(Suppl 3):S210-S214.
3. Coutinho ZF, Silva D, Lazera M, Petri V, Oliveira RM, Sabroza C, Wanke B. 2002. Paracoccidioidomycosis mortality in Brazil (1980-1995). Cad Saude Publica 18:1441-1454.
4. Ramos-e-Silva M, Saraiva LES. 2008. Paracoccidioidomycosis. Dermatol. Clin. 26:257-269.
5. Cavassani KA, Campanelli AP, Moreira AP, Vancim JO, Vitali LH, Mamede RC, Martinez R, Silva JS. 2006. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J. Immunol. 177:5811-5818.
6. Moreira AP, Cavassani KA, Tristao FSM, Campanelli AP, Martinez R, Rossi MA, Silva JS. 2008. CCR5-dependent regulatory T cell migration mediates fungal survival and severe immunosuppression. J. Immunol. 180:3049-3056.
7. Zarini S, Gijon MA, Ransome AE, Murphy RC, Sala A. 2009. Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation. Proc. Natl. Acad. Sci. U. S. A. 106:8296-8301.
8. Serhan CN. 2007. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25:101-137.
9. Peters-Golden M, Brock TG. 2003. 5-Lipoxygenase and FLAP. Prostaglandins Leukot. Essent. Fatty Acids 69:99-109.
10. Lewis RA, Austen KF, Soberman RJ. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645-655.
11. Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A. 2002. Lipoxinmediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3:76-82.
12. Bafica A, Scanga CA, Serhan C, Machado F, White S, Sher A, Aliberti J. 2005. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase- dependent lipoxin production. J. Clin. Invest. 115:1601-1606.
13. Kurita N, Sano A, Coelho KI, Takeo K, Nishimura K, Miyaji M. 1993. An improved culture medium for detecting live yeast phase cells of Paracoccidioides brasiliensis. J. Med. Vet. Mycol. 3:201-205.
14. Singer-Vermes LM, Ciavaglia MC, Kashino SS, Burger E, Calich VL. 1992. The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis. J. Med. Vet. Mycol. 30:261-264. 15. Calich VL, Purchio A, Paula CR. 1979. A new fluorescent viability test for fungi cells. Mycopathologia 66:175-177.
15. Calich VL, Purchio A, Paula CR. 1979. A new fluorescent viability test for fungi cells. Mycopathologia 66:175-177.
16. Pamplona FA, Menezes-de-Lima O, Jr, Takahashi RN. 2010. Aspirintriggered lipoxin induces CB1-dependent catalepsy in mice. Neurosci. Lett. 470:33-37.
17. Stenfeldt AL, Karlsson J, Wenneras C, Bylund J, Fu H, Dahlgren C. 2007. Cyclosporin H, Boc-MLF, and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation 30:224-229.
18. Green LC, Tannenbaum SR, Goldman P. 1981. Nitrate synthesis in the germfree and conventional rat. Science 212:56-58.
19. Pina A, Bernardino S, Calich VL. 2008. Alveolar macrophages from susceptible mice are more competent than those of resistant mice to control initial Paracoccidioides brasiliensis infection. J. Leukoc. Biol. 83:1088-1099.
20. Moreira AP, Campanelli AP, Cavassani KA, Souto JT, Ferreira BR, Martinez R, Rossi MA, Silva JS. 2006. Intercellular adhesion molecule-1 is required for the early formation of granulomas and participates in the resistance of mice to the infection with the fungus Paracoccidioides brasiliensis. Am. J. Pathol. 169:1270-1281.
21. Souto JT, Aliberti JC, Campanelli AP, Livonesi MC, Maffei CM, Ferreira BR, Travassos LR, Martinez R, Rossi MA, Silva JS. 2003. Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-infected mice is modulated by interferon-gamma. Am. J. Pathol. 163:583-590.
22. Robb RJ, Munck A, Smith KA. 1981. T cell growth factor receptors: quantitation, specificity, and biological relevance. J. Exp. Med. 154:1455-1474.
23. Nascimento FR, Calich VL, Rodriguez D, Russo M. 2002. Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility. J. Immunol. 168:4593-4600.
24. Jansen A, Lewis S, Cattell V, Cook HT. 1992. Arginase is a major pathway of L-arginine metabolism in nephritic glomeruli. Kidney Int. 42:1107-1112.
25. Livonesi MC, Souto JT, Campanelli AP, Maffei CM, Martinez R, Rossi MA, Silva JS. 2008. Deficiency of IL-12p40 subunit determines severe paracoccidioidomycosis in mice. Med. Mycol. 46:637-646.
26. Peres CM, de Paula L, Medeiros AI, Sorgi CA, Soares EG, Carlos D, Peters-Golden M, Silva CL, Faccioli LH. 2007. Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis. Microbes Infect. 9:483-489.
27. Gavins FN, Yona S, Kamal AM, Flower RJ, Perretti M. 2003. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related antiinflammatory mechanisms. Blood 101:4140-4147.
28. Bae YS, Lee HY, Jo EJ, Kim JI, Kang HK, Ye RD, Kwak JI, Ryu SH. 2004. Identification of peptides that antagonize formyl peptide receptorlike 1-mediated signaling. J. Immunol. 173:607-614.
29. Aliberti J, Bafica A. 2005. Anti-inflammatory pathways as a host evasion mechanism for pathogens. Prostaglandins Leukot. Essent. Fatty Acids 73: 283-288.
30. Panagio LA, Tristao FSM, Moreira AP, Pereira MS, Cavassani KA, Milanezi CM, Rossi MA, Silva JS. 2008. Role of interleukin (IL)-18 in experimental paracoccidioidomycosis. Med. Mycol. 46:435-442.
31. Cavassani KA, Tristao FSM, Oliveira LL, Rocha FA, Vancim JO, Moreira AP, Campanelli AP, Panagio LA, Milanezi CM, Martinez R, Rossi MA, Silva JS. 2011. Cell-free antigens from Paracoccidioides brasiliensis drive IL-4 production and increase the severity of paracoccidioidomycosis. PLoS One doi:10.1371/journal.pone.0021423.
32. Moscardi-Bacchi M, Franco M. 1985. Experimental paracoccidioidomycosis in the mouse. III. Histopathological and immunological findings after intravenous infection in the presence or absence of previous immunization. Rev. Soc. Bras. Med. Trop. 18:101-108.
33. Pavanelli WR, Gutierrez FR, Mariano FS, Prado CM, Ferreira BR, Teixeira MM, Canetti C, Rossi MA, Cunha FQ, Silva JS. 2010. 5-Lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes Infect. 12:587-597.
34. Aliberti J, Serhan C, Sher A. 2002. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 196:1253-1262.
35. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167:6533-6544.
36. Martinez FO, Sica A, Mantovani A, Locati M. 2008. Macrophage activation and polarization. Front. Biosci. 13:453-461.
37. Herbert DR, Orekov T, Roloson A, Ilies M, Perkins C, O'Brien W, Cederbaum S, Christianson DW, Zimmermann N, Rothenberg ME, Finkelman FD. 2010. Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J. Immunol. 184:6438-6446.
38. + Treg cells. Cell Mol. Immunol. 7:414-418.
39. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.